Skip to main content
logo
XORTX Therapeutics Inc. (XRTX)
0.3791
+0.0341 (9.88%)
Inactive · Last trade price on Mar 27, 2026

XORTX Therapeutics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Income
-3.12-3.26-4.12-6.05-10.29-2.91
Net Income
-0.81-2.66-3.31-2.16-7.72-1.58
Earnings Per Share
-2.48-2.80-5.75-5.45-26.10-7.20
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
0.250.862.473.4510.4314.91
Total Debt
0.020.040.040.010.080
Net Cash (Debt)
0.240.832.433.4410.3614.91
Net Cash Growth
-87.49%-66.03%-29.14%-66.82%-30.56%10985.81%
Net Cash Per Share
0.210.874.238.6734.9968.16

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-2.63-2.77-3.68-6.58-8.17-4.8
Capital Expenditures
----0-0.02-
Free Cash Flow
-2.63-2.77-3.68-6.59-8.19-4.8
Free Cash Flow Growth
------